Rawalpindi: Ferozsons Laboratories Limited has issued a formal notice for its 70th Annual General Meeting (AGM), slated to convene on Wednesday, October 28, 2026, at 12:45 P.M. The meeting is scheduled to be held at Blue Lagoon, Masood Akhter Kiani Road, Rawalpindi, with provisions for participation via video-link.

The agenda for this AGM encompasses several key items under ordinary business. The meeting will begin with the confirmation of minutes from the Extraordinary General Meeting conducted on July 3, 2026. The attendees will then review and adopt the audited financial statements for the fiscal year that concluded on June 30, 2026. This includes examining the Chairperson's Review and the Directors' and Auditors' reports.

A significant point of discussion will be the proposed final cash dividend for the year ended June 30, 2026. The Board of Directors has recommended a dividend rate of 55%, equivalent to Rs. 5.50 per share, which awaits approval from the members. Additionally, the meeting will address the appointment of auditors for the year ending June 30, 2027, along with the determination of their remuneration.

Under special business, the AGM will deliberate on the ratification and confirmation of related party transactions conducted during the financial year 2025-26. The Board of Directors seeks authorization to approve such transactions in the future. The resolutions related to this matter will be passed as 'Special Resolutions', as disclosed in note 39 of the unconsolidated financial statements for the year ended June 30, 2026.

According to information available from the Pakistan Stock Exchange (PSX), Ferozsons Laboratories Limited is categorized under the designated market category of the pharmaceutical sector. This notification of the AGM holds significance for stakeholders and investors associated with the company.

The meeting will conclude with the consideration of any other business that may be brought forward with the chair's permission.